National Research Corporation logo

National Research Corporation (NR1A)

Market Open
27 Feb, 20:00
XMUN XMUN
11. 00
0
0%
- Market Cap
33.66 P/E Ratio
0.64% Div Yield
0 Volume
0 Eps
11
Previous Close
Day Range
11 11
Year Range
9.35 18.6
Want to track NR1A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NRC earnings report is expected in 55 days (27 Apr 2026)

Summary

NR1A trading today higher at €11, an increase of 0% from yesterday's close, completing a monthly decrease of -35.67% or €6.1. Over the past 12 months, NR1A stock lost -31.25%.
NR1A pays dividends to its shareholders, with the most recent payment made on Jan 09, 2026. The next announced payment will be in In 1 month on Apr 10, 2026 for a total of €0.16.
The last earnings report, released on Feb 09, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on Apr 27, 2026.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

NR1A Chart

NRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27%

NRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27%

NRC Health's Q4 EPS and revenues decline year amid prior client attrition, though recurring contract value grew 8%, pointing to recovery prospects in 2026.

Zacks | 3 weeks ago
National Research Corporation (NRC) Q4 2025 Earnings Call Prepared Remarks Transcript

National Research Corporation (NRC) Q4 2025 Earnings Call Prepared Remarks Transcript

National Research Corporation (NRC) Q4 2025 Earnings Call Prepared Remarks Transcript

Seekingalpha | 3 weeks ago
National Research: The Turnaround Is Invisible Until It Isn't

National Research: The Turnaround Is Invisible Until It Isn't

National Research Corp. is undervalued, trading at a modest multiple despite a clear pivot from contraction to growth. TRCV, NRC's key forward metric, grew 8% YoY, signaling imminent revenue acceleration and a strong 2026 setup. Margins are expanding as cost structure is rationalized; normalized FCF could approach $38M in 2026 after one-off expenses subside.

Seekingalpha | 1 month ago

National Research Corporation (NR1A) FAQ

What is the stock price today?

The current price is €11.00.

On which exchange is it traded?

National Research Corporation is listed on XMUN.

What is its stock symbol?

The ticker symbol is NR1A.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.64%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Apr 27, 2026.

Has National Research Corporation ever had a stock split?

No, there has never been a stock split.

National Research Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Trent Green CEO
XMUN Exchange
US6373722023 ISIN
US Country
368 Employees
10 Apr 2026 Last Dividend
- Last Split
10 Oct 1997 IPO Date

Overview

Founded in 1981 and based in Lincoln, Nebraska, National Research Corporation is a leader in delivering comprehensive analytics and insights designed to enhance both patient and employee experiences within the healthcare sector. The company's offerings span across critical areas such as patient experience, service recovery, care transitions, and employee engagement, among others. Its mission is to provide healthcare organizations with actionable information and analysis that support improvement initiatives, reputation management, and brand loyalty efforts. National Research Corporation's solutions cater to a wide array of needs, aligning with the goals of maximizing constituent satisfaction and organizational effectiveness in healthcare settings.

Products and Services

National Research Corporation's suite of products and services is meticulously crafted to address various facets of healthcare organization needs, with a focus on delivering actionable insights for improvement and strategic management. Key offerings include:

  • Analytics and Insights: These tools are designed to measure and enhance patient and employee experiences, offering a foundation for targeted interventions in service recovery and care transitions. By leveraging these insights, healthcare organizations can better understand and act on the complex dynamics affecting patient and employee satisfaction.
  • Marketing Solutions: Focused on elevating healthcare brands, these solutions track brand awareness, perception, and consistency. Competitor differentiators are assessed, and advanced segmentation tools are employed to discern community needs, preferences, and behaviors, enabling real-time competitive assessments.
  • Experience Solutions: This category includes tailored solutions aimed at improving patient experience and employee engagement, through health risk assessments, care transition tools, and other targeted improvement instruments. These services empower health organizations to deepen their understanding of and response to the experiences of their patients and staff.
  • Reputation Solutions: To bolster healthcare organizations' public image, these solutions facilitate the distribution of timely and relevant content that shapes consumer perceptions and informs decision-making. They are designed to ensure that the organization's narrative is positively reflected in the public domain.
  • Governance Solutions: Specifically designed for the boards of directors, executives, and physician leaders of not-for-profit hospitals and health systems, these services offer strategic oversight tools and resources. They support effective governance practices, ensuring that leadership is aligned with both mission and performance objectives.

Contact Information

Address: 1245 Q Street
Phone: 402 475 2525